Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 816

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7A
Chunk 816
---
. The policy is administered by our Board of Directors
or, if so designated by the Board of Directors, the Compensation Committee. Any determinations made by the Board shall be final and binding
on all affected individuals.

80

The
individuals covered by this policy (the “Covered Officers”) are any current or former employee who is or was identified as
our president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller),
any vice-president in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other
officer who performs a significant policy-making function, or any other person (including any executive officer of our subsidiaries or
affiliates) who performs similar significant policy-making functions for us.

The
policy covers our recoupment of “Incentive-Based Compensation” (as defined in the policy) received by a person after beginning
service as a Covered Executive and who served as a Covered Officer at any time during the performance period for that Incentive Compensation.
In the event we are required to prepare an accounting restatement, the policy requires us to recover, reasonably promptly, any excess
incentive compensation (as determined by our Board of Directors or Compensation Committee) received by any Covered Officer during the
three completed fiscal years immediately preceding the date on which we are required to prepare such accounting restatement. The foregoing
description of our Compensation Recovery Policy does not purport to be complete and is qualified in its entirety by the terms and conditions
of such policy, a copy of which is filed as an exhibit to this Report and is incorporated herein by reference.

Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The
following table sets forth, as of the date of this Report, the ownership of our securities by: (i) each of our directors, (ii) all persons
who, to our knowledge, are the beneficial owners of more than 5% of the outstanding shares of common stock, (iii) each of the executive
officers, and (iv) all of our directors and executive officers, as a group. Each person named in this table has sole investment power
and sole voting power with respect to the shares of common stock set forth opposite such person’s name, except as otherwise indicated.

    Name
    and Address of Beneficial Owner 
    Amount
                                            and Nature
                                                                                                  of
                                            Beneficial
                                                                                                  Ownership